Thep53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers
- 1 June 1996
- journal article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 122 (6) , 360-365
- https://doi.org/10.1007/bf01220804
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- Cancer Therapy Meets p53New England Journal of Medicine, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- Thymocyte apoptosis induced by p53-dependent and independent pathwaysNature, 1993
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- p53 allele losses, mutations and expression in breast cancer and their relationship to clinico‐pathological parametersInternational Journal of Cancer, 1992
- p53 point mutations in primary human gastric carcinomasZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- p53 Mutations in Human CancersScience, 1991